Team
We are a team of experts in molecular biology, regulatory management, and clinical development
Leadership
Daniel Dornbusch, MPH MBA
Chief Executive Officer
TJ Cradick, Ph.D.
Chief Scientific Officer
Christine Silverstein
Chief Financial Officer
Jennifer Gordon, Ph.D.
Senior Vice President, R&D
Sara Turken, J.D.
General Counsel
William Kennedy, M.D.
Senior Vice President, Clinical
Rose Ann Branca
Vice President, Clinical Operations
Team
Panos Argiras
Senior Director, External Manufacturing
Lucas Buchheim-Jurisson
Associate Director, Corporate Strategy
Elvin Ruan
Senior Director, Genome Editing
Salvatore Amato
Senior Director, Finance
Ryo Takeuchi
Director, Genome Editing
Qin Xiang
Director, Analytical Development and QC
Meltem Isik
Associate Director, Bioinformatics
Wenwen Huo
Senior Computational Biologist
Sam Slattery
Senior Scientist, Nonviral Delivery
Nadia Amrani, Ph.D.
Associate Director, Genome Editing
Kevin Luk, Ph.D.
Scientist, Genome Editing
Shari Fox
Senior Clinical Trial Manager
Pamela Castillo
Senior Corporate Development Associate
R&D Partners
Kamel Khalili, Ph.D.
Chief Scientific Founder
Temple University,
School of Medicine
Tricia Burdo, Ph.D.
Preclinical R&D
Temple University,
School of Medicine
Ilker Sariyer, DVM Ph.D.
Research Investigator
Temple University,
School of Medicine
Amir Khalili, M.S.
Program Manager
Temple University, School of Medicine
Board of Directors
Daniel Dornbusch, MPH MBA
Chief Executive Officer, Excision
Bill Carson, M.D.
Chairman of the Board, Otsuka Pharmaceutical Development & Commercialization, Inc.
Ashok Krishnamurthi
Managing Partner,
GreatPoint Ventures
Vasudev Bailey, Ph.D.
Partner, Artis Ventures
Jeff Kindler
Chief Executive Officer,
Centrexion Therapeutics
Scientific Advisory Board
John Baxter, M.D.
Cooper University Medical Center
(HIV Clinician)
​
Toni Cathomen, Ph.D.
Albert-Ludwigs-Universitat Freiburg
(Gene Therapy)
​
Joseph Berger, M.D.
Perelman School of MedicineUniversity of Pennsylvania
(JC Virus & PML)
​
Nicole Paulk, Ph.D.
University of California San Francisco
(Oncology & AAV)
​
Lisa Danzig, M.D.
Life Sciences Executive
(Global Health)
David Thomas, M.D.
Johns Hopkins School of Medicine
(Hepatitis B)
​
David Clifford, M.D.
Washington University School of Medicine in St. Louis
(PML and HIV)
Joseph Bondy-Denomy, Ph.D.
​University of California San Francisco
(CRISPR Inhibitors)
​
Keith Jerome, M.D., Ph.D.
Fred Hutchinson Cancer
Research Center
(Herpes Simplex Viruses, Hepatitis B)
​
Kamel Khalili, PhD
Temple University School of Medicine (Neurovirology and Gene Therapy)
​
Mike Walker, Ph.D.
Stanford University
(Bioinformatics)
​
Kenneth L. Tyler, M.D.University of Colorado Denver – Anschutz Medical Campus(JC Virus & PML)
​
Timothy M. Block, Ph.D.
Baruch S. Blumberg Institute
(Hepatitis B)
​
​
​
​
​
Business Advisory Board
Annalisa Jenkins, M.B.B.S., F.R.C.P.
Biopharma & Life Sciences Executive
Jeff Kindler
CEO, Centrexion Therapeutics
Mark Pruzanski, M.D.​
Former CEO Intercept, Apple Tree Partners, Oak Investments
Michael Marks
Founding Managing Partner, Celesta Capital
Paul Sekhri
President and CEO, eGenesis
Sandy Zweifach
Former CEO Nuvelution Pharma, Ascendency Healthcare, Reedland Captial, Pathways Diagnostics, CFO Bay City Capital